Biosimilars in IBD: hope or expectation?

Krisztina B. Gecse; Reena Khanna; Gijs R. van den Brink; Cyriel Y. Ponsioen; Mark Löwenberg; Vipul Jairath; Simon P. L. Travis; William J. Sandborn; Brian G. Feagan; Geert R. A. M. D'Haens

doi:https://doi.org/10.1136/gutjnl-2012-303824

Biosimilars in IBD: hope or expectation?

Krisztina B. Gecse, Reena Khanna, Gijs R. van den Brink, Cyriel Y. Ponsioen, Mark Löwenberg, Vipul Jairath, Simon P. L. Travis, William J. Sandborn, Brian G. Feagan, Geert R. A. M. D'Haens

Research output: Contribution to journal › Editorial › Academic › peer-review

45 Citations (Scopus)

Original language	English
Pages (from-to)	803-807
Journal	Gut
Volume	62
Issue number	6
DOIs	https://doi.org/10.1136/gutjnl-2012-303824
Publication status	Published - 2013

Access to Document

https://doi.org/10.1136/gutjnl-2012-303824

Cite this

@article{a4a27bae1a034539b90af95bb4ca640b,

title = "Biosimilars in IBD: hope or expectation?",

author = "Gecse, {Krisztina B.} and Reena Khanna and {van den Brink}, {Gijs R.} and Ponsioen, {Cyriel Y.} and Mark L{\"o}wenberg and Vipul Jairath and Travis, {Simon P. L.} and Sandborn, {William J.} and Feagan, {Brian G.} and D'Haens, {Geert R. A. M.}",

year = "2013",

doi = "https://doi.org/10.1136/gutjnl-2012-303824",

language = "English",

volume = "62",

pages = "803--807",

journal = "Gut",

issn = "0017-5749",